Fisher Wallace Laboratories Email Format
Medical Equipment ManufacturingNew York, United States11-50 Employees
Fisher Wallace Labs has validated its wearable brain stimulation technology as the most effective self-administered treatment for depression and anxiety. The company's proof-of-concept device is used by over 60,000 patients, and its Version 2.0 device, OAK, was designed and engineered in collaboration with the teams behind Beats and Nest to achieve smartphone scale. With the support of clinical advisors including Dr. Maurizio Fava, Psychiatrist-in-Chief of Massachusetts General Hospital, and Dr. David Shulkin, former US Secretary of Veterans Affairs, OAK is on track for regulatory approval in 2025.